Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Lumentum (LITE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Lumentum — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.36 (market cap $5.85B), while Lumentum trades at $1,090.5 (market cap $100.64B). The key difference: Lumentum is far larger — about 17.2× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is more actively traded (14,517,176 versus 3,383,346). Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Lumentum for 4 Days on average.
| IOVA | LITE | |
|---|---|---|
Market Cap | $5.85B | $100.64B |
Volume | 14,517,176 | 3,383,346 |
Sector | Health | Technology |
52-Week High | $14.82 | $1.13K |
52-Week Low | $1.81 | $149.61 |
Typical Hold Time | 0 Days | 4 Days |
Enterprise Value | $5.78B | $99.58B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Lumentum
Lumentum develops photonic products, including optical components, transceivers, and lasers. Its technologies support data centers, communications networks, industrial manufacturing, and sensing applications.
Read more on LITE →
